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Abstract
We develop an approach to tag proteomes synthesized by specific cell-types in dissociated cortex, 
brain slices, and the brain of live mice. By viral-mediated expression of an orthogonal pyrrolysyl-
tRNA synthetase/tRNAXXX pair in a cell type of interest and providing a non-canonical amino 
acid with a chemical handle, we selectively label neuronal or glial proteomes. The method enables 
the identification of proteins from spatially and genetically defined regions of the brain.
Determining the proteomes of specific cells is a particular challenge in the mammalian 
central nervous system (CNS), where cell types form a network with dense chemical, 
electrical and physical connectivity1, 2. Efforts to elucidate proteomes of specific cell types 
in the CNS have used i) primary cell cultures or ii) cells that are acutely separated from 
tissue, by ex vivo manipulations, and purified on the basis of cell surface markers, for 
analysis3. However, the resulting cells are no longer in their physiological network, and may 
lose cellular structures (and their associated proteins), as well as chemical, electrical and 
physical connectivity3, 4. Thus, isolated and cultured cells are likely to have adapted 
proteomes; the proteomes of cultured cells and acutely isolated cells are clearly different 
from each other3, and it is unclear how these proteomes relate to the proteome in vivo.
4Correspondence: chin@mrc-lmb.cam.ac.uk. 
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We previously reported stochastic orthogonal recoding of translation (SORT) for cell-type 
specific tagging of proteomes, to enable labeling and identification of proteins from targeted 
cells without dissection5, 6. In SORT an orthogonal pyrrolysyl-tRNA synthetase-tRNAXXX 
pair (where XXX indicates an anticodon sequence, and the pair is derived from 
Methanosarcina species, most commonly M. Mazei or M. barkeri) is expressed in the cell of 
interest. This pair recognizes an added noncanonical amino acid (ncAA) substrate 
containing a bioorthogonal cyclopropene group (CypK), and decodes a specific sense codon 
in competition with an endogenous aminoacyl-tRNA synthetase-tRNAXXX pair, leading to 
stochastic and low level tagging of the proteome with CypK. The tagged proteome can be 
labelled (SORT-M) or enriched and identified (SORT-E) (Supplementary Fig. 1). We have 
demonstrated SORT in Escherichia coli, cultured mammalian cells, and Drosophila 
melanogaster 5, 6, but not in any live vertebrate.
The CypK used for SORT in cultured cells and flies is prohibitively expensive for large 
animal experiments. We set out to develop SORT with Nε- (propargyloxycarbonyl)-L-lysine, 
AlkK (1, see Supplementary Fig. 2 for chemical structures), a substrate for PylRS7 that is 50 
times cheaper than CypK to synthesize, metabolically stable in the mouse, and available in 
the mouse brain through drinking water8. We optimized selective labeling of an AlkK-
tagged E. coli proteome with an Azide-AlexaFluor 647 conjugate (Az-AF647) 
(Supplementary Fig. 3).
We constructed AAV vectors in which a mCherry-P2A-MmPylS genetic fusion is expressed 
from the neuron-specific, human synapsin 1 (hSyn1) promoter9, and PylTCAU (encoding 
Pyrrolysyl-tRNACAU) is expressed from the U6 promoter (Supplementary Fig. 4)8. We 
transduced primary dissociated rat neocortex, containing neurons and glia, with our hSyn1 
mCherry-P2A-MmPylS/PylTCAU (hSyn1-SORTCAU) AAV in the presence of AlkK (Fig. 
1A). Following transduction, mCherry was clearly visible in neurons (NeuN positive cells) 
but not in GFAP positive glia (Fig. 1B). We observed selective fluorescent labeling of this 
co-culture with Az-AF647 that was dependent on AlkK; labeling co-localized with both 
NeuN and mCherry, but not GFAP (Fig. 1B). Moreover, a lysate from the co-culture 
receiving AlkK was selectively labelled with Az-AF647. (Supplementary Figs. 5).
We transduced slices of the mouse suprachiasmatic nucleus (SCN)8 with the hSyn-
SORTCAU AAV, added AlkK, and confirmed subsequent AAV-dependent mCherry 
expression (Fig. 1C). We selectively labelled tagged proteins with Az-AF647 (Fig. 1D. and 
Supplementary Fig. 6 for all full gels). We demonstrated that SORT can be extended to 
tagging proteomes in a set of glial cells (astrocytes and ependymal cells10, 11) by creating a 
GFAP mCherry-P2A-MmPylS/PylTCAU (GFAP-SORTCAU) AAV (Fig. 1C, D and 
Supplementary Fig. 4). GFAP-driven SORT led to the expected mCherry expression pattern 
in the SCN12 (Fig. 1C), and the GFAP positive proteome was labelled at a comparable level 
to the neuronal proteome (Fig. 1D). Circadian oscillations can be followed in SCN slices 
derived from Period2::LUC mice by bioluminescence, and these oscillations are known to be 
sensitive to cellular, electrical, or signalling perturbations of the SCN network8. We found 
that Per2::LUC organotypic SCN slices (slices that maintain their function in culture) that 
were transduced with hSyn I-SORTCAU or GFAP-SORTCAU AAVs and supplemented with 
AlkK retained robust circadian rhythms (Fig. 1E).
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Unilateral stereotactic injections of the hSyn1-SORTCAU AAV into the corpus striatum of 
right hemisphere of adult mice were followed one week later by addition of AlkK to the 
drinking water. Coronal sections from the brains of the mice, after one week on AlkK, 
revealed asymmetric mCherry fluorescence, primarily localized to the right hemisphere (Fig. 
2A, Supplementary Fig. 7A). mCherry fluorescence co-localized with NeuN but not with 
GFAP (Fig. 2B). We labelled protein extracts from the striatum of each hemisphere with Az-
AF647 and observed selective labeling of the proteome from the right hemisphere (Fig. 2C). 
The efficiency of SORT tagging in mice was comparable to that in E. coli (Supplementary 
Fig. 8).
We compared the total striatal proteome of control mice, and mice subject to SORT tagging 
in both hemispheres (Supplementary Fig. 9). We found a strong correlation (Pearson 
correlation coefficient= 0.98) between the proteomes, comparable to the correlation between 
independent SORT proteomes (0.98) or the correlation between independent control 
proteomes (0.98). Similarly, we found an excellent correlation (0.98) between the proteomes 
of mice fed AlkK or injected with the hSyn1-SORTCAU AAV and the control proteome. The 
mice subject to SORT were healthy and maintained their body weight throughout the study 
(Supplementary Fig. 9).
We also carried out unilateral stereotactic injections of the hSyn1-SORTCAU or GFAP-
SORTCAU AAV into the hippocampus in the right hemisphere of adult mice (Supplementary 
Fig. 7B, Supplementary Fig. 7C). We observed selective labeling of the proteome from the 
right hemisphere of the hippocampus via SORT-M, co-localizing either with neurons or 
GFAP positive cells (Supplementary Fig. 10), and demonstrating the approach can be used 
in different regions of the brain.
Numerous mouse strains have been created in which Cre recombinase is expressed in 
targeted cell types in the mouse brain13. We generated the hSyn1-FLEX-SORTCAU AAV 
(Supplementary Fig. 4), which facilitates the irreversible Cre-mediated flipping of an 
inverted mCherry-P2A-MmPylS gene cassette, for expression from the upstream 
promoter14, 15. We observed SORT tagging when we injected the hSyn1-FLEX-SORTCAU 
AAV into the let striatum of Vgat-Cre mice (expressing Cre in inhibitory GABAergic 
neurons) (Fig. 2D), but not in mice lacking Cre recombinase. We also injected the hSyn1-
FLEX-SORTCAU AAV into the hippocampus of the right hemisphere in Vgat-Cre mice and 
Vglut-Cre mice (expressing Cre subset of excitatory neurons) and observed proteome 
tagging in both cases (Fig. 2E-J and Supplementary Fig. 7D, E).
Next we tagged the proteome of neurons in the striatum, expecting to primarily tag proteins 
from medium spiny neurons (MSNs) involved in the post-synaptic side of dopaminergic 
synapses and glutamatergic synapses, and both the pre-synaptic and post-synaptic side of 
GABAergic synapses, as well as, potentially, interneurons16 (Supplementary Fig. 11). We 
developed a SORT-E protocol for AlkK tagged proteomes (Supplementary Fig. 12). We 
prepared lysates from the striatum of brains of mice bilaterally injected with the hSyn1-
SORTCAU AAV and provided with AlkK, covalently labelled the resulting proteome with an 
azide-diazobenzene-biotin conjugate (2)17, 18 (Supplementary Fig. 2), captured the 
proteome on streptavidin beads, washed extensively, and then cleaved the diazobenzene 
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linker to provide a SORT-E output (Supplementary Fig. 1). We observed clear enrichment of 
the SORT-E output with respect to non-tagged control outputs (Fig. 2K).
By tandem mass spectrometry (MS/MS) analysis we assessed the relative abundance of each 
protein in the SORT-E output to its abundance in the control output (Fig. 2L, Supplementary 
Data 1). For 96% of the 2119 proteins captured this ratio is >1, demonstrating the specificity 
of the enrichment protocol for SORT tagged proteins. We identified 1789 proteins, defined 
as SORT-E IDs, that are enriched in the SORT tagged proteome compared to the control 
(1604 proteins, S0:1, false-discovery rate (FDR) < 0.05), or are found in three independent 
replicates of the SORT tagged proteome, but only zero or one time in six independent 
controls (185 proteins) (Supplementary Data 1). In contrast we found only 24 proteins that 
are enriched in the control proteome (7 proteins, S0:1, FDR<0.05), or are only found in the 
control proteome (17 proteins). The SORT-E IDs define a set of proteins from the 
genetically targeted striatal neurons (Fig. 2L).
Established neuronal markers, are enriched in the SORT-E output, as are canonical markers 
of MSNs (Fig. 2L, Supplementary Table 1). Neuronal proteins were significantly enriched in 
SORT-E IDs (P(neuron part)= 2.8x10-7), but not in SORT-E NS (P(neuron part)=0.17), with 
respect to the total striatal proteome (Fig. 2L). SORT-E IDs include several markers of 
GABAergic synapses, as well as established markers of the post-synaptic side of 
glutamatergic synapses and dopaminergic synapses (Supplementary Table 1, Supplementary 
Fig. 13)
The majority of glial markers are not enriched in the SORT-E output, consistent with the low 
expression of many glial markers in neurons (Fig. 2L), and most glial markers are de-
enriched by SORT-E with respect to the striatal proteome (Fig. 2M). We found that proteins 
identified as glial-specific, in glia isolated from mouse brains, but not those identified as 
glial specific, from cultured glia3, are significantly de-enriched by SORT-E (P=3.38x10-5 
and P=0.17, respectively) (Fig. 2N, O).
We have demonstrated a modular approach to co-translational proteome tagging in specific 
cells in primary culture, in mouse organotypic tissues slices and in the brains of live mice. 
Our approach complements a very recently described approach for cell specific proteome 
tagging19. Because our SORT approach uses viral injection in combination with specific 
promoters it provides independent special and genetic control of proteome tagging. 
Extensions of SORT may introduce additional chemistries into the mouse proteome20, 
including photo-crosslinkers to interrogate cell-type specific protein interactions, and may 
be extended to additional codons to provide greater proteome coverage5.
Online Methods
Additional information can be found in the "Life Sciences Reporting Summary" that 
accompanies this manuscript.
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Materials
AAV serotype 1 viral vectors were obtained commercially from the Penn Vector Core. All 
animal work was licensed under the UK Animals (Scientific Procedures) Act of 1986 with 
local ethical approval (MRC AWERB, Cambridge University). At least two mice were used 
for every condition tested, mice were not excluded, no randomization or blinding was used.
Chemical synthesis
All solvents and chemical reagents were purchased from Sigma-Aldrich or Fisher Scientific, 
and used without any further purification. The synthesis of Nε- (tert-butyloxycarbonyl)-L-
lysine, “AlkK”, (amino acid 1) was previously reported6. The synthesis of Azide 
diazobenzene biotin, “ADB”, (compound 2) was as reported17.
Proteomic incorporation of AlkK via SORT into E. coli proteome
Chemically competent E. coli DH10B cells (50 µL) were doubly transformed with 
pBAD_wtT4L_MbPylT-AGA plasmid6 (2 µL, necessary for expression of PyltRNA-AGA) 
and pBK-MbPylS plasmid6 (2 µL necessary for expression of PylRS). Transformed cells 
were recovered in 1 ml S.O.B. (supplemented with 0.2% glucose) for 1 h at 37 °C. 100 µL of 
the recovery was used to inoculate 50 ml LB-KT (50 µg/ml kanamycin and 25 µg/ml 
tetracycline) and the cultures incubated overnight (37 °C, 250 r.p.m.). Overnight cultures 
were diluted to OD600 0.1 with LBKT½ (as LBKT, but with half the concentration of 
antibiotics) and divided into two 200 mL cultures. One culture was supplemented with AlkK 
(1 mM final concentration) and other with H2O (200 µL). Cultures were then incubated 
(37 °C, 250 r.p.m.) for 6 h. Cells were harvested by centrifugation (4,000 r.p.m., 4 °C, 20 
min) and then washed two times by resuspending in 25 mL of ice cold PBS, and collecting 
by centrifugation (4,000 r.p.m., 4 °C, 20 min) between each wash. The final cell pellets were 
immediately frozen for storage.
Optimised SORT-M labeling of E. coli protein lysates
Frozen cell pellets were thawed and resuspended in 8M urea (PBS, pH 7.8, 5 mL). Cells 
were lysed on ice using a microtip sonicator (amplitude 15, 11 m total sonication time, 
Soniprep 150 plus). Protein concentrations were determined by BCA assay (Pierce). For a 
typical SORT-M experiment 100 µL of protein lysate (~10 mg/mL) was first reduced with 3 
mM DTT (3 µL of 100 mM stock solution, 1 hr at RT) and alkylated in 16.5 mM 
iodoacetamide (16.5 µL of 100 mM stock solution, 1 hr at RT in dark). The lysates were 
then ligated with the addition of 100 µM Azide-AlexaFluor647 dye (2 µL of 5 mM stock 
solution in DMSO, ThermoFisher), 5 mM aminoguanidine (5 µL of 100 mM stock solution) 
and freshly made 50X “click mix” (2 µL of 50 mM CuSO4, 50 mM TBTA (tris[(1-
benzyl-1H-1,2,3-triazol-4-yl)methyl]amine) and 100 mM sodium ascorbate made in 1:1 
DMSO:H2O, final concentration of Cu, TBTA and ascorbate in reaction should be 1, 1, and 
2 mM respectively). The samples were then incubated at room temperature for 4 hrs or 
overnight with end-over-end rotation (Hula mixer). Reactions were quenched with the 
addition of 1 mM AlkK 1. 2 µL aliquots (20 µg of protein) were used for 4-12% Bis-Tris 
SDS-Page gels and imaged on a Typhoon gel imager (excitation 633 nm/emission 670 nm). 
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The gels were then stained with Coomassie stain (Expedeon) and imaged on a BioRad Gel 
Doc XR System.
Plasmid construction
First, the hU6-PylTCAU gene was cloned by standard molecular biology protocols in a 
divergent orientation at the XbaI site upstream of the human Synapsin 1 promoter in pAAV-
hSyn1-hChR2(H134R)-EYFP (Addgene #26973). Into this backbone, the 
mCherry::P2A::MmPylS, coding sequence was cloned between the BamHI and EcoRI sites. 
The GFAP mCherry-P2A-MmPylS/PylTCAU was cloned by promoter replacement, the 
GFAP promoter refers to GfaABC1D promoter throughout. The hSyn1 FLEX mCherry-
P2A-MmPylS/PylTCAU (hSyn1-FLEX-SORTCAU) was constructed by transferring loxP and 
lox2272 sites from pAAV-hSyn-DIO-HA-hM3D(Gq)-IRES-mCitrine (a gift from Bryan 
Roth, Addgene plasmid #50454) into the hSyn1-SORTCAU plasmid via 4-piece Gibson 
assembly.
Primary culture of dissociated rat cortical neurons and glial cells
Dissociated rat cortical neurons (RCNs) were prepared as reported previously8. Brains of 
E17 fetuses from time-mated rats were dissected, trypsinised in presence of 1% (wt/vol) 
DNAse I (HT Biotechnology) and triturated with a 1 ml Gilson pipette. Dissociated cells 
were seeded at density of 20,000-50,000 cells/cm2 onto poly-l-lysine coated coverslips or 
poly-l-lysine coated polystyrene plates. The cells were cultured in Neurobasal media 
supplemented with B27 and GlutaMAX (ThermoFisher) at 37°C under 5% CO2 atmosphere. 
The cells were initially seeded in presence of 2.5% fetal bovine serum, switching to serum-
free media after 24 hours. Subsequently, half of the media was exchanged every 5 days.
SORT in dissociated rat cortical neurons and glial cells
Dissociated cultures were transduced after culturing for 3 days by addition of 1-2 µL 
(~1012-1013 transducing units) of pSynI-mCherry::P2A::MmPylS/PylTCAU AAV particles 
into a single well of 6-well plates or 8-well coverslips, and the media was supplemented 
with 1 mM AlkK 1 at this time. Half of the media was exchanged every 5 days with or 
without the corresponding amino acid. The cells were analyzed 14 days post transduction. 
For lysate analysis, cells were washed with HBSS and incubated for 30 mins on ice in RIPA 
buffer (10 mM Tris/Cl pH 7.5; 150 mM NaCl; 0.5 mM EDTA; 0.1% SDS; 1% Triton X-100; 
1% Deoxycholate) supplemented with protease inhibitor cocktail (Roche). The lysates were 
centrifuged for 10 min at 20,000 x g (4°C), collecting the supernatant for analysis. For 
labeling and immunofluorescence, the cells were washed once with HBSS (ThermoFisher) 
and fixed with 4% (v/v) paraformaldehyde in HBSS.
Labeling of fixed cells, immunofluorescence and confocal imaging
Fixed cells were permeabilized by 0.5% Triton-X100 and blocked with 3% BSA for 1 hr at 
room temperature. For click labeling, 5 mM aminoguanidine (Sigma) and 5 uM Azide-
AlexaFluor647 dye (ThermoFisher) solution was added to the cells, followed by addition of 
1mM CuSO4 (Sigma), 1mM sodium ascorbate (Sigma) and 1 mM TBTA (tris[(1-
benzyl-1H-1,2,3-triazol-4-yl)methyl]amine). The cells were incubated in the reaction 
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mixture for 1 hr at room temperature and then washed with PBS. The cells were 
subsequently immunostained with anti-NeuN (Abcam, ab177487) and anti-GFAP (Abcam, 
ab4674) antibodies (1:300 dilution in 3% BSA) overnight at 4°C, washed again, and then 
stained for 1 hr at room temperature with corresponding secondary antibodies (A-31556 and 
A-11039, ThermoFisher) (1:300 dilution in 3% BSA). Confocal fluorescence images were 
acquired on a Leica SP8 inverted confocal microscope with appropriate filter settings. The 
presented images were created as maximum projections (in Z-axis) from Z-stacks stepping 
through the entire cell height.
SORT-M in SCN Slices
SCN organotypic slices were prepared from 7-9 day old C57/BL6 or Per2::LUC pups as 
reported previously3. Slices were transduced with 1 µL (~1012-1013 transducing units) of 
hSyn1-mCherry::P2A::MmPylS/PylTCAU AAV particles. After two weeks slices were 
transferred to culture media with 15 mM AlkK 2. The slices were imaged after one week of 
SORT labeling on a Leica DM IL LED inverted fluorescent microscope with QCapture Suite 
PLUS software. After imaging, the SCN slices were subsequently lysed by sonication in 8 
M urea (PBS, pH 7.8) for subsequent fluorescent labeling of AlkK containing proteins. 
Protein concentrations were determined by BCA assay (Pierce).
Bioluminescence recordings of Per2::Luciferase SCN slices
Seven days after dissection of Per2::Luciferase SCN slices from the same litter, the slices 
were transduced with hSyn1-mCherry::P2A::MmPylS/PylTCAU or the corresponding GFAP 
AAV, transferred to a medium with 1 mM luciferin and placed into photo-multiplier tubes to 
record circadian oscillation as a bioluminescence signal as previously described8. After two 
weeks the medium was supplemented with 15 mM AlkK 1 and the bioluminescence signal 
was recorded for the successive 7 days during SORT protein labeling.
SORT in live mice
Adult male or female C57/BL6J, Vgat-Cre (JAX 016962) and Vglut-Cre (JAX 016963) mice 
aged 10 weeks, weighing between 18-26 g were housed on a 12 hour light/dark cycle in 
cages with ad libitum access to food and water. No randomization or blinding was uses. The 
only exclusion criteria for animals were health issues. For viral injections, animals were 
anesthetized with 2% isofluorane and placed in a stereotaxic frame (David Kopf 
Instruments, Tujunga, CA). The mice received either unilateral or bilateral stereotactic 
injections of 2 µl of AAV1.hSyn1-mCherry::P2A::MmPylS/PylTCAU, AAV5.GFAP-
mCherry::P2A::MmPylS/PylTCAU or AAV1. hSyn1-FLEX-mCherry::P2A::MmPylS/
PylTCAU particles (2.0 µL of ~5 x 1012 GC/mL; ~1 x 1010 viral particles) into the region of 
the striatum (-1.7 mm medio-lateral, +0.7 mm anterior, -3.6 mm dorsal relative to bregma) 
or the dorsal hippocampus (-2.0 mm medio-lateral, -2.55 mm anterior, -2.0 mm dorsal 
relative to bregma). Injections were performed using a 5 µl Hamilton syringe with a 33 
gauge needle and a microsyringe pump controller (Micro4, World Precision Instruments) at 
flow rate of 0.5 µl/min. The needle was left in place at the injection site for 2 min before 
being slowly withdrawn. Two weeks after the surgery, the mice received AlkK, 1, 
administered orally in the drinking water (15 % black currant-flavored water containing 30 
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mg/mL AlkK 1) or control drink with no AlkK 1 for one additional week. After the seven 
days of AlkK treatment, the mice were sacrificed, and the brains were either post-fixed in 
4% paraformaldehyde and preserved in 30% sucrose for sectioning or dissected to remove 
the striatum or hippocampus, which was frozen on dry-ice for further analyses. To assess the 
effect of the different components of the SORT labeling system, we injected mice with 
hSyn1-SORT AVV and fed them AlkK for a week ”SORT-E” while in parallel creating three 
control groups: mice only injected with AAV ”AAV”, fed only AlkK “AlkK” or neither 
AAV nor AlkK “Control”. The striatal tissues from all four groups were lysed in 8M urea 
and separated on SDS-PAGE before subjecting the gel slices to LC-MS/MS,
Immunofluorescence microscopy and confocal imaging of brain sections
Fixed and cryopreserved brains (unilaterally injected) were cut into 40 µm coronal sections 
on a freezing microtome. For observation of mCherry fluorescence (PylS expression) 
throughout the brain, coronal sections from anterior to posterior were mounted with hardset 
VECTASHIELD H-1500 with DAPI (Vectorlabs) and images were acquired with a 4x 
objective on a Nikon Eclipse TE2000 microscope and processed in ImageJ (NIH). 
Immunostaining for co-localization was performed by overnight incubation with monoclonal 
rabbit anti-NeuN (Abcam, AB177487; 1:250) and polyclonal chicken anti-GFAP 
(MerckMillipore, AB5541; 1:500) and mounted with VECTASHIELD H-1500 with DAPI 
(Vectorlabs). Confocal images were acquired on a Zeiss LSM 710 confocal microscope and 
processed in ImageJ (NIH).
Fluorescent labeling of protein lysates
Cell, SCN and brain lysates (Striatal and Hippocampal) were first reduced in 3 mM DTT (1 
hr at RT) and then alkylated in 16.5 mM iodoacetamide (30 min at RT in dark). For SORT-M 
using AlkK, the lysates were then supplemented with 100 µM Azide-AlexaFluor647 
(ThermoFisher), 5 mM aminoguanidine, and “click mix” (1 mM CuSO4, 1 mM TBTA 
(tris[(1-benzyl-1H-1,2,3-triazol-4-yl)methyl]amine) and 2 mM sodium ascorbate (final 
concentrations), made as 50X mix in 1:1 DMSO:H2O). The samples were then incubated at 
room temperature for 4 hrs or overnight. All labeled samples were separated on 4-12% Bis-
Tris SDS-Page gels and imaged on a Typhoon gel imager (excitation 633 nm/emission 670 
nm). The gels were then stained with Coomassie stain (Expedeon) and imaged on a BioRad 
Gel Doc XR System.
Optimised SORT-E for E. coli lysate
Frozen cell pellets were thawed and resuspended in 8M urea (PBS, pH 7.8, 5 mL). Cells 
were lysed on ice using a microtip sonicator (amplitude 15, 11 m total sonication time, 
Soniprep 150 plus). Protein concentrations were determined by BCA assay (Pierce). For a 
typical SORT-E experiment 4 mL of protein lysate (~10 mg/mL) was first reduced with 3 
mM DTT (24 µL of 500 mM stock solution, 1 hr at RT) and alkylated in 16.5 mM 
iodoacetamide (66 µL of 1 M stock solution, 1 hr at RT in dark). The lysates were then 
ligated with the addition of 100 µM azide-diazobenzene-biotin 2 (8 uL of 5 mM stock 
solution in DMSO), 5 mM aminoguanidine (20 µL of 1 M stock solution) and freshly made 
50X “click mix” (80 µL of 50 mM CuSO4, 50 mM TBTA (tris[(1-benzyl-1H-1,2,3-triazol-4-
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yl)methyl]amine) and 100 mM sodium ascorbate made in 1:1 DMSO:H2O, final 
concentration of Cu, TBTA and ascorbate in reaction should be 1, 1, and 2 mM 
respectively). The samples were then incubated at room temperature overnight with end-
over-end rotation (Hula mixer). Reactions were quenched with the addition of 1 mM AlkK 
1. 10 µL aliquots were taken at this stage as the input sample for subsequent SDS-PAGE 
analysis. The samples were precipitated by the addition of 10 volumes of ice-cold methanol 
and incubated at -20 °C overnight. Precipitated protein was collected by centrifugation 
(3200 rcf), and the supernatant decanted. The protein pellets washed with ice-cold methanol 
(2 x 25 mL), collected by centrifugation (3200 rcf), and re-dissolved in urea buffer (5 mL, 8 
M urea, PBS, pH 7.8). 100 µL of high capacity streptavidin beads slurry (Thermo scientific) 
were added to the re-dissolved proteins and incubated with end-over-end rotation (Hula 
mixer) for 1.5 hours, then collected by filtration through a spin column (Mini Bio-spin® 
chromatography column Bio-Rad 731-1550). Unbound proteins were washed away by 
suspending beads in 1% SDS in PBS (500 µL) with 2 minute end-over-end rotation (Hula 
mixer), and then collecting the beads by a short centrifugation (1000 rpm, 5 second pulse). 
This washing process was repeated 5 times. An aliquot of the final wash was kept for 
analysis by SDS-PAGE. Specifically bound proteins were then eluted by resuspending the 
beads in 1% SDS in PBS supplemented with 50 mM Na2S2O4 (100 µL) and incubating at 
room temperature for 30 minutes with end-over-end rotation (Hula mixer). The supernatant 
was collected by centrifugation (1000 rpm, 5 second pulse). The elution was repeated two 
more times (50 µL), and the fractions pooled. 10% of the elutant was used for analysis by 
SDS-PAGE.
SORT-E from the striatal tissue of live mice
Striatal tissue from five brains (bilaterally injected, n=3) were pooled and lysed in 1.5 mL of 
8 M urea (PBS, pH 7.8) and homogenized with a disposable pestle. The tissue homogenates 
were sonicated in a water bath and subsequently cleared by centrifugation. Protein 
concentrations were determined by BCA assay (Pierce), and 1.3 mL of mouse striatal 
protein lysate (~8 mg/mL) was reduced with 3 mM DTT (1 hr at RT) and alkylated in 16.5 
mM iodoacetamide (30 min at RT in dark). The lysates were then supplemented with 100 
µM azide-diazobenzene-biotin 2, 5 mM aminoguanidine and “click mix” (1 mM CuSO4, 1 
mM TBTA (tris[(1-benzyl-1H-1,2,3-triazol-4-yl)methyl]amine) and 2 mM sodium ascorbate 
(final concentrations), made as 50X mix in 1:1 DMSO:H2O). The samples were then 
incubated at room temperature for 4 hrs with end-over-end rotation (Hula mixer). Reactions 
were quenched with the addition of 1 mM AlkK 1. 10 µL aliquots were taken at this stage as 
the input sample for subsequent SDS-PAGE analysis. The samples were precipitated by the 
addition of 10 volumes of ice-cold methanol and incubated at -20 °C overnight. Precipitated 
protein was collected by centrifugation (3200 rcf), and the supernatant decanted. The protein 
pellet was wash with ice-cold methanol (5 mL), collected by centrifugation (3200 rcf), and 
re-dissolved in urea buffer (1.5 mL, 8 M urea, PBS, pH 7.8). 50 µL of high capacity 
streptavidin beads settled resin (Thermo scientific) were added to the re-dissolved proteins 
and incubated with end-over-end rotation (Hula mixer) for 1.5 hours, then collected by 
filtration through a spin column (Mini Bio-spin® chromatography column Bio-Rad 
731-1550). Unbound proteins were washed away by suspending beads in 1% SDS in PBS 
(500 µL) with 2 minute end-over-end rotation (Hula mixer), and then collecting the beads by 
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a short centrifugation (1000 rpm, 5 second pulse). This washing process was repeated 15 
times. An aliquot of the final wash was kept for analysis by SDS-PAGE. Specifically bound 
proteins were then eluted by resuspending the beads in 1% SDS in PBS supplemented with 
50 mM Na2S2O4 (50 µL) and incubating at room temperature for 30 minutes with end-over-
end rotation (Hula mixer). The supernatant was collected by centrifugation (1000 rpm, 5 
second pulse). The elution was repeated three times, and the fractions pooled. 10% of the 
elutant was used for analysis by SDS-PAGE. The remaining elutant was concentrated to ~30 
µL using a centrifugal filter unit (3000 kDa cut-off amicon), and loaded into a 10% SDS-
PAGE gel (15 min run) before each lane was cut into two bands for LC-MS/MS analysis.
LC-MS/MS analysis (striatal SORT-E)
Each gel slice was subjected to in-gel tryptic digestion using a DigestPro automated 
digestion unit (Intavis Ltd.) to minimise manual handling. The resulting peptides were 
fractionated using an Ultimate 3000 nanoHPLC system in line with an Orbitrap Fusion 
Tribrid mass spectrometer (Thermo Scientific). In brief, peptides in 1% (vol/vol) formic acid 
were injected onto an Acclaim PepMap C18 nano-trap column (Thermo Scientific). After 
washing with 0.5% (vol/vol) acetonitrile 0.1% (vol/vol) formic acid, peptides were resolved 
on a 250 mm × 75 µm Acclaim PepMap C18 reverse phase analytical column (Thermo 
Scientific) over a 150 min organic gradient, using 7 gradient segments (1-6% solvent B over 
1 min., 6-15% B over 58 min., 15-32% B over 58 min., 32-40% B over 5 min., 40-90% B 
over 1 min., held at 90% B for 6 min and then reduced to 1% B over 1 min.) with a flow rate 
of 300 nl min−1. Solvent A was 0.1% formic acid and Solvent B was aqueous 80% 
acetonitrile in 0.1% formic acid. Peptides were ionized by nano-electrospray ionization at 
2.2 kV using a stainless steel emitter with an internal diameter of 30 µm (Thermo Scientific) 
and a capillary temperature of 250 °C.
All spectra were acquired using an Orbitrap Fusion Tribrid mass spectrometer controlled by 
Xcalibur 2.0 software (Thermo Scientific) and operated in data-dependent acquisition mode. 
FTMS1 spectra were collected at a resolution of 120,000 over a scan range (m/z) of 
350-1550, with an automatic gain control target of 400,000 and a max injection time of 100 
ms. Precursors were filtered with an intensity range from 5E3 to 1E20, according to charge 
state (to include charge states 2-7) and with monoisotopic precursor selection. The Data 
Dependent mode was set to TopSpeed and the most intense ions were selected for MS/MS. 
Precursors were filtered according to charge state (to include charge states 2-7) and with 
monoisotopic precursor selection. Previously interrogated precursors were excluded using a 
dynamic window (40 s +/-10 ppm). The MS2 precursors were isolated with a quadrupole 
mass filter set to a width of 1.6 m/z. ITMS2 spectra were collected with an AGC target of 
5000, max injection time of 50 ms and HCD collision energy of 35%.
MS data analysis
MS raw files were processed using the MaxQuant software21 (version 1.5.0.0) and searched 
with the embedded Andromeda search engine22 against the reviewed mouse sequence 
database (Uniprot). Cysteine carbamidomethylation was set as a fixed modification and N-
acetylation of protein and oxidation of methionine as variable modifications. Peptides with a 
minimum of seven amino acids were considered and the required FDR was set to 1% at 
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peptide and protein levels. The maximum allowed missed cleavages was set to two. Protein 
quantification was done by label free quantification (Fast LFQ) with default settings.
Downstream processing of mass spectrometry data was done with Perseus23 from the 
MaxQuant ProteinGroups output file, contaminations and reverse hits were removed by 
filtering. The remaining protein quantifications were log2 transformed.
Statistics and reproducibility
Figure 1b, the experiment was repeated 2 times, using independent cultures with similar 
results.
Figure 1c, the experiment was repeated 2 times, using independent slices, with similar 
results.
Figure 1d, the experiment was repeated 3 times, using independent slices, with similar 
results.
Figure 1e, the experiment was repeated 2 times, using independent slices, with similar 
results.
Figure 2a, the injection was repeated 3 independent times with similar results.
Figure 2b, the immunofluorescence and fluorescence was repeated on 3 sections from two 
independent mice with similar results.
Figure 2c, the gel and imaging was repeated 2 independent times with similar results.
Figure 2d, the gel and imaging was repeated 2 independent times with similar results.
Figure 2e, the injection was repeated 3 independent times with similar results.
Figure 2f, the immunofluorescence and fluorescence was repeated on 3 sections with similar 
results.
Figure 2g, the gel and imaging was repeated 2 independent times with similar results.
Figure 2h, the injection was repeated 3 independent times with similar results.
Figure 2i, the immunofluorescence and fluorescence was repeated on 3 sections with similar 
results.
Figure2j, the gel and imaging was repeated 2 independent times with similar results.
Figure 2k, each lane represents an independent SORT-E experiment derived from n=5 mice.
Figure 2l, Each Log2(SORT-E Output/Control Output) data point is calculated in Perseus 
using n=3 SORT-E output measurements and n=6 Control output measurements. The SORT-
E IDs were defined from the Log2(SORT-E Output/Control Output) with a significance 
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curve S0=1 FDR<0.05, plus the proteins only identified in SORT-E output, but not in the 
control output (Supplementary Data 1).
The SORT-E ID proteome (1789 proteins) and the SORT-E NS (608 proteins) were 
submitted to DAVID bioinformatics24 with a background proteome of 3787 proteins 
(Supplementary Data 1) defined as proteins identified by LC-MS/MS across all our samples, 
including gel band fractionated (three bands) load of 15 µg total striatum protein lysate. 
From the GO:Cellular Compartment (CC_FAT) the Benjamini-Hockberg p-values for GO:
0097458 “Neuron Part” were reported for SORT-E ID and SORT-E NS.
Figure 2m, Log2(LFQSORT-E Output / LFQTotal Striatum), LFQ is the label free quantification 
value from LC-MS/MS analysis. The depletion of glial markers (Oligodendrocyte markers: 
Plp1, Mog, Mag, Cnp, Mbp, ,Enpp6, Bcas1; Astrocytes markers: Slc1a2, Scl1a3, GFAP, 
Aldh1l1, Vim, Glul, S100b) was calculated and plotted as Log2 mean values with standard 
error of mean, n=3 independent experiments. Statistics were calculated with a one-sample t-
test (H0:µ=0) and the significance of the two tailed test were reported as *P-value<0.05 and 
** P-value<0.005. P values were Plp1 (0.022), Mog (0.007), Mag (0.006), Cnp (0.037), Mbp 
(0.230), Enpp6 (0.049), Bcas1 (0.086), Slc1a2 (0.069), Scl1a3 (0.006), GFAP (0.0008), 
Aldh1l1 (0.165), Vim (0.0157), Glul (0.024), S100b (0.319).
Figure2n, Proteins that are >10 fold upregulated in cultured glia with respect to neurons in 
Sharma et al3 and are present in the SORT-E output were mapped onto proteins that are 
"SORT-E De-enriched " (LFQSORT-E Output / LFQTotal Striatum < 1), and proteins that are 
"SORT-E Enriched" (LFQSORT-E Output / LFQTotal Striatum > 1). The Euler diagram indicates 
the number of proteins found in each category. Hypergeometric distribution probability 
analyses were then used to calculate a P value for the significance of the proteins from 
cultured glia in "SORT-E De-enriched" and for the significance of the proteins from cultured 
glia in "SORT-E Enriched".
Figure2o, proteins that are >10 fold upregulated in acutely isolated glia with respect to 
neurons in Sharma et al3 and are present in the SORT-E output were mapped and analyzed 
as described in panel N.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Cell-type specific labeling of proteomes.
A. Schematic of cell-type specific labeling in complex tissue. Promoter (Prom.) directs 
SORT tagging system to targeted cell type. B. SORT-M in the neurons of dissociated rat 
cortex. Selective labeling of neurons with Azide-AlexaFluor 647 (Az-AF647) in cells 
cultured with AlkK. Scale bar, 50 µm. C. mCherry::P2A::PylS expression in Organotypic 
SCN slices upon infection with the indicated hSyn or GFAP driven AAV SORT system. 
Scale bar, 300 µm. D. SORT-M labeling of proteomes from SCN slices infected with the 
indicated hSyn or GFAP driven AAV SORT system, provided with AlkK and labeled with 
Az-AF647. The Coomassie gel is a loading control for the fluorescent gel. E. Organotypic 
slices of the mouse SCN derived from Period2::LUC mice were transduced with the hSyn1-
SORTCAU or GFAP- SORTCAU AAV and transferred to fresh media supplemented with 
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AlkK. Rhythms were followed by bioluminescence. Information on statistics and 
reproducibility for all panels are provided in the Online methods section.
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Figure 2. Spatially controlled cell-type specific labeling in live mice.
A. Section of a brain unilaterally injected with hSyn1-SORTCAU AAV into the right striatum 
and fed AlkK. Scale bar, 1000 µm. B. Fluorescence and immunostaining of brain sections 
from a mouse treated as in A. Scale bar, 50 µm. C. Az-AF647-labelled lysates from the right 
(SR) and left (SL) striatum of mice treated as in A. D. SDS-PAGE analysis of Az-AF647-
labelled lysates from WT or Vgat-Cre mice injected with the hSyn1-FLEX-SORTCAU AAV 
in the left hemisphere, provided with AlkK. E. Section from a Vgat-Cre brain injected with 
hSyn1-FLEX-SORTCAU AAV in the hippocampal right hemisphere and fed AlkK. Scale bar, 
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1000 µm. F. Fluorescence and immunostaining for right hippocampus of a Vgat-Cre mouse, 
treated as described in E. Scale bar, 50 µm. G. SDS-PAGE analysis of Az-AF647-labeled 
protein extracts from the right (R) and left (L) hippocampus of Vgat-Cre mice, as described 
in E.. H.-J., as for E.-G., but using Vglut-Cre mice. K. SDS-PAGE of the elution from 
replicates of striatal SORT-E experiments. Each lane is eluted from five mice. L. (SORT-E 
output/control output) represents the ratios of the raw intensities. Dotted line represents the 
cut off curve for significance (S0=1, FDR<0.05). Glial (yellow), neuronal (red). The P values 
for neuron part are from GO analysis. Each Log2(SORT-E output/control output) data point 
is calculated in Perseus using n=3 SORT-E output measurements and n=6 Control output 
measurements. M. The y axis is the Log2 ratio of the label free quantification value. The 
data show mean of independent three independent replicates, ± s.e.m. *P<0.05, **P<0.005 
for a ratio < 0. Statistics were calculated with a one-sample t-test (H0:µ=0) and the 
significance of the two tailed test were reported N. Euler diagram indicates the partitioning 
of glial specific proteins in cultured glia between SORT-E enriched and de-enriched. O. As 
for N, but using glial specific proteins from acutely isolated glia. Information on statistics 
and reproducibility for all panels are provided in the Online Methods.
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